Treatment of Hypertrophic Scars With Intradermal Botox

Status unconfirmed · Phase 2

Conditions studied: Hypertrophic Scar

In brief

This is a prospective, open label, single center, self-controlled clinical study to demonstrate the safety and efficacy of intradermal botulinum toxin in treating hypertrophic scarring.

Key facts

Study ID
NCT03631368
Run by
Roy G. Geronemus, M.D.
People needed
20
Starts
2018-10-01
Expected to finish
2019-05-31
Last updated by the study team
2018-09-26

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.